Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies (NQ: DVAX )

12.42 +0.06 (+0.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 902,686
Open 12.32
Bid (Size) 12.16 (1)
Ask (Size) 13.00 (1)
Prev. Close 12.36
Today's Range 12.31 - 12.58
52wk Range 9.740 - 15.01
Shares Outstanding 128,489,060
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript
DVAX earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)
From Glancy Prongay & Murray LLP
Via Business Wire

Performance

YTD
-13.63%
-13.63%
1 Month
+15.32%
+15.32%
3 Month
+8.95%
+8.95%
6 Month
+8.00%
+8.00%
1 Year
-8.41%
-8.41%

More News

Read More
Insights into Dynavax Technologies's Upcoming Earnings
Via Benzinga
Lantheus Appoints Julie Eastland as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
Assessing Dynavax Technologies: Insights From 4 Financial Analysts
Via Benzinga
Dynavax Technologies: Q4 Earnings Insights
Via Benzinga
Earnings Preview For Dynavax Technologies
Via Benzinga
Preview: Dynavax Technologies's Earnings
Via Benzinga
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVAX Stock Earnings: Dynavax Technologies Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
Via Benzinga
Exposures Product Safety
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Vera Therapeutics Stock Soared by 22% This Week
Via The Motley Fool
3 Stocks Set to Soar 68% to 200% Higher
Via InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why
Via Benzinga
Dynavax Technologies Stock Sees Renewed Technical Strength
Via Investor's Business Daily
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
Via Benzinga
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.